Career | <?phpecho $jobTitle;?> | <?phpecho $companyName;?>

Director, Financial Planning & Analysis

Revolution Medicines

Redwood City, CA, US
  • Job Type: Full-Time
  • Function: Accounting/Finance
  • Industry: Biotechnology
  • Post Date: 07/08/2024
  • Website:
  • Company Address: 700 Saginaw Dr, Redwood City, California 94063, US

About Revolution Medicines

REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients.

Job Description

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding scientists in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity

Reporting directly to VP, FP&A and Strategy, this newly created role will be a key contributor to financial modeling associated with portfolio strategy, the assessment of external collaboration and partnership opportunities, and long-range planning. This position is based out of our headquarters in Redwood City, CA.

Specifically, you will be responsible for: 

  • Create and maintain financial models (P&L, Valuation, NPV, DCF) that help guide near and long-term portfolio planning and decision making.

  • Provide finance support and develop financial models to assist in business development and corporate strategy efforts.

  • Assist in maintenance and update of the long-range financial model.

  • Conduct scenario and sensitivity analyses

  • Support and provide financial insights for portfolio planning and prioritization.

  • Deliver clear, articulate analyses and insights to inform decisions for single assets and larger portfolio.

  • Effectively partner with multiple functions to align on key assumptions, including commercial organization for revenue projections and program management for probability of technical and regulatory success (PTRS).

  • Ad-hoc financial analysis support.

Required Experience, Skills and Education:

  • Bachelor’s degree and 10+ years of relevant experience in finance, banking, and/or consulting.

  • Experience in oncology preferred.

  • Advanced excel-based modelling experience.

  • Strong analytical and strategic thinking skills.

  • Excellent written and verbal communication skills.

  • Ability to lead teams and collaborate cross-functionally.

  • Initiative-taking and able to work independently.

  • Resourceful, motivated, and able to identify potential issues or problems and find solutions.

The expected salary range for this role is $195,000 to $245,000. An individual’s position within the range may be influenced by multiple factors, including skills and experience in role, overall performance, individual impact and contributions, tenure, and market dynamics. Base salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition and veteran status.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact

We use cookies to customize your user experience. Click “Agree” if you agree with our Policy.